Subscribe to RSS
DOI: 10.1055/s-0043-1771442
Translation and Pilot Validation of Hindi, Marathi, and Bangla Translation of Quality-of-Life EORTC Radiation Proctitis Module (PRT-20) for Routine Clinical Use
Abstract
The aim of this study was to translate and validate the European Organization for Research and Treatment for Cancer (EORTC) “Radiation Proctitis” (PRT-20) module in Hindi, Marathi, and Bangla languages. The EORTC PRT-20 was translated into Hindi, Marathi, and Bangla using EORTC guidelines. Two separate translators first translated the original questionnaire into the three regional languages, following which a reconciled forward translation was compiled. This reconciled version in each language was then back-translated into English by two other translators. This back-translated version was then compared with the original the EORTC questionnaire for correctness, and the preliminary questionnaires were formed in all three languages. The EORTC translation unit approved the questionnaires. The preliminary questionnaires were administered to 30 patients (10 for each language) diagnosed with rectal or anal canal cancer who had received pelvic radiotherapy and were at risk of developing PRT. None of the patients had seen the questionnaire before. After filling out the questionnaire, each patient was interviewed for difficulty in answering, confusion, understanding, or if any of the questions were upsetting and if patients would have asked the question differently. No changes were suggested for Marathi and Bangla translations. Two modifications were suggested in the Hindi translation, which was then retested in five patients and finalized. All the suggestions were incorporated into the preliminary questionnaires, which were sent back to the EORTC for final approval. After reviewing the entire report of pilot testing for the translated quality-of-life questionaire-PRT-20 in three languages, it was approved by the EORTC translation unit. The translated questionnaires were reliable, with Cronbach α values of 0.767, 0.799, and 0.898 for Hindi, Marathi, and Bangla, respectively. The Hindi, Marathi, and Bangla translations of PRT-20 have been approved by the EORTC and can be used in routine clinical practice.
Publication History
Article published online:
12 September 2023
© 2023. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Andreyev HJ, Wotherspoon A, Denham JW, Hauer-Jensen M. Defining pelvic-radiation disease for the survivorship era. Lancet Oncol 2010; 11 (04) 310-312
- 2 Hille A, Schmidberger H, Hermann RM. et al. A phase III randomized, placebo-controlled, double-blind study of misoprostol rectal suppositories to prevent acute radiation proctitis in patients with prostate cancer. Int J Radiat Oncol Biol Phys 2005; 63 (05) 1488-1493
- 3 Ferini G, Pergolizzi S. A ten-year-long update on radiation proctitis among prostate cancer patients treated with curative external beam radiotherapy. In Vivo 2021; 35 (03) 1379-1391
- 4 Cheng YK, Qin QY, Huang XY. et al. Effect of interval between preoperative radiotherapy and surgery on clinical outcome and radiation proctitis in rectal cancer from FOWARC trial. Cancer Med 2020; 9 (03) 912-919
- 5 Halkett GKB, Wigley CA, Aoun SM. et al; EORTC Quality of Life Group. International validation of the EORTC QLQ-PRT20 module for assessment of quality of life symptoms relating to radiation proctitis: a phase IV study. Radiat Oncol 2018; 13 (01) 162
- 6 Kuliś D, Bottomley A, Velikova G, Greimel E. Koller M - on behalf of the EORTCQuality of Life Group - “EORTC Quality Of Life Group Translation Procedure”.(4rdedition). EORTC, Brussels: (2017).
- 7 Accessed June 25, 2023 at: https://qol.eortc.org/questionnaire/qlq-prt23/
- 8 Aaronson NK, Ahmedzai S, Bergman B. et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85 (05) 365-376
- 9 Chaukar DA, Das AK, Deshpande MS. et al. Quality of life of head and neck cancer patient: validation of the European organization for research and treatment of cancer QLQ-C30 and European organization for research and treatment of cancer QLQ-H&N 35 in Indian patients. Indian J Cancer 2005; 42 (04) 178-184
- 10 Budrukkar A, Jalali R, Kamble R, Parab S. Translation and pilot validation of Hindi translation of assessing quality of life in patients with primary brain tumours using EORTC brain module (BN-20). J Cancer Res Ther 2006; 2 (04) 166-170
- 11 Parmar V, Badwe RA, Hawaldar R. et al. Validation of EORTC quality-of-life questionnaire in Indian women with operable breast cancer. Natl Med J India 2005; 18 (04) 172-177
- 12 Pandey M, Thomas BC, Ramdas K, Eremenco S, Nair MK. Reliability & validity of the Malayalam functional assessment of cancer therapy for head & neck cancer. Indian J Med Res 2004; 120 (01) 51-55
- 13 Joshi A, Kalra D, Menon N. et al. Translation and validation of COST - FACIT (Version 2) questionnaire into Hindi and Marathi to assess financial toxicity in Indian cancer patients. South Asian J Cancer 2022; 11 (02) 97-104
- 14 Manjali JJ, Gupta T, Ghosh-Laskar S, Jalali R, Sarin R, Agarwal JP. Pilot testing and vernacular translation of a questionnaire for assessment of satisfaction in patients on radiotherapy in India. Indian J Cancer 2021; 58 (04) 573-582